Leyk, E.; Środa, M.; Maślanka, G.; Nowaczyk, P.; Orzołek, A.; Grodzka, H.; Kurek, A.; Knut, O.; Michalak, J.; Płachciak, J.;
et al. Analysis of the Effect of the Tablet Matrix on the Polymorphism of Ibuprofen, Naproxen, and Naproxen Sodium in Commercially Available Pharmaceutical Formulations. Methods Protoc. 2025, 8, 99.
https://doi.org/10.3390/mps8050099
AMA Style
Leyk E, Środa M, Maślanka G, Nowaczyk P, Orzołek A, Grodzka H, Kurek A, Knut O, Michalak J, Płachciak J,
et al. Analysis of the Effect of the Tablet Matrix on the Polymorphism of Ibuprofen, Naproxen, and Naproxen Sodium in Commercially Available Pharmaceutical Formulations. Methods and Protocols. 2025; 8(5):99.
https://doi.org/10.3390/mps8050099
Chicago/Turabian Style
Leyk, Edyta, Marcin Środa, Gracjan Maślanka, Patrycja Nowaczyk, Amelia Orzołek, Hanna Grodzka, Aleksandra Kurek, Olaf Knut, Julia Michalak, Jonatan Płachciak,
and et al. 2025. "Analysis of the Effect of the Tablet Matrix on the Polymorphism of Ibuprofen, Naproxen, and Naproxen Sodium in Commercially Available Pharmaceutical Formulations" Methods and Protocols 8, no. 5: 99.
https://doi.org/10.3390/mps8050099
APA Style
Leyk, E., Środa, M., Maślanka, G., Nowaczyk, P., Orzołek, A., Grodzka, H., Kurek, A., Knut, O., Michalak, J., Płachciak, J., & Plenis, A.
(2025). Analysis of the Effect of the Tablet Matrix on the Polymorphism of Ibuprofen, Naproxen, and Naproxen Sodium in Commercially Available Pharmaceutical Formulations. Methods and Protocols, 8(5), 99.
https://doi.org/10.3390/mps8050099
